IGF-1 increases cardiac output, stroke volume, contractility, and ejection fraction, aiding recovery after myocardial infarction
Because the first phase is absent or inadequate, the second phase is late to release and often excessive as the body tries to compensate
Semaglutide enhances metabolic health by promoting significant weight loss, improving cardiovascular outcomes, reducing inflammation markers, and optimizing lipid profiles beyond glucose regulation
This effect helps control blood glucose but can produce digestive symptoms resembling gastroparesis in some patients
Many people find symptoms ease by weeks 48
How should I use levocarnitine